Search
Menu
Home
HTB
2021
August
HTB
August 2021
Contents
Editorial
HTB: no. 8 – plus HIV and COVID-19 (1 August 2021)
Conference reports
11th IAS Conference on HIV Science (IAS 2021)
IAS 2021: lenacapavir studies show impressive results in naive, extensive drug resistance and potential as PrEP
IAS 2021: HIV pipeline drugs: CAB/RPV LA, fostemsavir, paediatric dolutegravir, lenacapavir, islatravir, MK-8507 and albuvirtide
IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies
IAS 2021: WHO report links HIV to 30% increased mortality from COVID-19: based on South African data
IAS 2021: New demands for better transgender heath care: No data no more
13th International Workshop on HIV Paediatrics 2021
Dolutegravir superior to standard-of-care in young children: results from the ODYSSEY trial
Coinfections and complications
UK Biobank study finds no link between CMV and cardiovascular disease: HIV not included
HIV prevention and transmission
Phase 1 HIV mosaic vaccine study launched at Oxford university
On the web
Ending the HIV epidemic (EHE) in the US
COVID-19: HIV and COVID-19 coinfection
Antibody responses to Pfizer vaccine in HIV positive people with high CD4 counts
COVID-19: vaccine research
Third dose of mRNA vaccine improves antibody responses in kidney transplant recipients
US CDC recommends third vaccine dose in some groups
Pfizer plans for third dose: questions over population need?
Efficacy of Oxford/AZ and Pfizer vaccines against Delta variant in the UK
Results from Novavax phase 3 study in the UK
WHO approves Chinese vaccines for emergency use
Selected other vaccine studies
Efficacy of Chinese CoronaVac vaccine in Chile national programme
COVID-19: investigational drugs
NHS supports selected use of inhaled budesonide for COVID-19 in people at risk of severe events
Reviews of ivermectin for COVID-19: no evidence of benefit from RCTs
RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19
COVID-19: pathogenesis
Variation in ACE2 levels are not related to outcomes from COVID-19
PDFs
HTB: no. 8 – plus HIV and COVID-19 (1 August 2021)
HTB RSS
Early access
In-utero tenofovir-based PrEP has no effect on children’s bone mineral density
25 September 2023
>10% weight gain during first two years of ART linked to double the risk of cardiometabolic disease
25 September 2023
Mutations associated with resistance to dapivirine vaginal ring: reported in 7/38 women seroconverting in the open-label HOPE study
25 September 2023
Early phase 1 HIV vaccine study launched in the US and South Africa
21 September 2023
All early access reports
Current issues
September 2023
August 2023
June 2023
Back issues
Special report
Latest statistics on HIV in the UK: data for 2021
1 December 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage